- World rank, all time
- #35,310 of 42,892
- Rank in Switzerland
- #363 of 429
- Research works
- 170 ▲ 118% vs 2013–17
- Citations
- 5.6k 33.1 per fractional work
- Top-10% rate
- 20.1% record average 16.5%
- Open access
- 51% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.0×. Every wedge is a field page.
- Medicine 4.0×
- Pharmacology, Toxicology and Pharmaceutics 3.5×
- Economics, Econometrics and Finance 2.8×
- Immunology and Microbiology 1.7×
- Nursing 1.6×
- Biochemistry, Genetics and Molecular Biology 1.5×
- Health Professions 0.8×
- Mathematics 0.3×
- Physics and Astronomy 0.2×
- Psychology 0.2×
- Agricultural and Biological Sciences 0.1×
- Materials Science 0.1×
- Social Sciences 0.1×
- Environmental Science 0.1×
- Engineering 0.0×
Who are the top researchers at Bayer (Switzerland)?
Ranked on the composite score, Noman Paracha and A. Gutmann lead among researchers whose main affiliation is Bayer (Switzerland).
- 1 Noman Paracha Switzerland · #1,435,975 worldwide 7 citations · 17 works
- 2 A. Gutmann Switzerland · #1,486,571 worldwide 14 citations · 16 works
Which keywords describe research at Bayer (Switzerland)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Clinical Trials, Hormone Therapy, Prostate Cancer, Genomic Profiling, Immunotherapy, Biomarkers, Genetic Mutations and Targeted Therapy.
- Vasomotor Symptoms
- Bone Mineral Density
- BRAF Mutation
- Precision Medicine
- Dosimetry
- Cancer Treatment
- Retinal Pigment Epithelium
- Cost-effectiveness Analysis
- Intravitreal Injection
- Depression
- Diabetic Retinopathy
- Oxidative Stress
- Chemotherapy
- Cardiovascular Disease
- Androgen Receptor
- Targeted Therapy
- Inflammation
- Quality of Life
- Genomic Profiling
- Hormone Therapy
- Clinical Trials
- Prostate Cancer
- Immunotherapy
- Biomarkers
- Genetic Mutations
- Epidemiology
- Metastatic Prostate Cancer
- Breast Cancer
- Vascular Endothelial Growth Factor
- Macular Degeneration
- Cognitive Function
- Estrogen
- Choroidal Thickness
- Health Utility Measures
- Screening
- Clinical Guidelines
- PET Imaging
- Treatment Guidelines
- Menopause
- Ovarian Cancer
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Clinical Trials7▲ 19×8 topics
- Hormone Therapy7▲ 148×3 topics
- Prostate Cancer7▲ 90×3 topics
- Genomic Profiling7▲ 111×2 topics
- Immunotherapy6▲ 15×9 topics
- Quality of Life5▲ 6.3×13 topics
- Biomarkers5▲ 13×7 topics
- Inflammation5▲ 4.2×23 topics
- Genetic Mutations5▲ 20×4 topics
- Targeted Therapy5▲ 38×4 topics
- Epidemiology5▲ 2.1×20 topics
- Androgen Receptor5▲ 111×1 topic
- Metastatic Prostate Cancer5▲ 200×1 topic
- Cardiovascular Disease4▲ 6.5×15 topics
- Breast Cancer4▲ 30×7 topics
- Chemotherapy4▲ 8.8×13 topics
- Vascular Endothelial Growth Factor4▲ 74×3 topics
- Oxidative Stress3▲ 3.6×12 topics
- Macular Degeneration3▲ 47×3 topics
- Diabetic Retinopathy3▲ 56×2 topics
- Cognitive Function3▲ 29×5 topics
- Depression3▲ 5.5×6 topics
- Estrogen3▲ 124×2 topics
- Intravitreal Injection3▲ 68×2 topics
- Choroidal Thickness2▲ 83×1 topic
- Cost-effectiveness Analysis2▲ 50×1 topic
- Health Utility Measures2▲ 50×1 topic
- Retinal Pigment Epithelium2▲ 83×1 topic
- Screening2▲ 45×2 topics
- Cancer Treatment2▲ 18×5 topics
- Clinical Guidelines2▲ 15×3 topics
- Dosimetry2▲ 57×2 topics
- PET Imaging2▲ 23×4 topics
- Precision Medicine2▲ 8.6×3 topics
- Treatment Guidelines2▲ 19×3 topics
- BRAF Mutation2▲ 52×2 topics
- Menopause2▲ 83×2 topics
- Bone Mineral Density2▲ 50×1 topic
- Ovarian Cancer2▲ 42×3 topics
- Vasomotor Symptoms2▲ 207×1 topic
Which research topics does Bayer (Switzerland) publish most on?
By volume in 2022–2025: Prostate Cancer Treatment and Research, Health Systems, Economic Evaluations, Quality of Life, Retinal Diseases and Treatments and Radiopharmaceutical Chemistry and Applications.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 5 works
- 2 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 2 works
- 3 Retinal Diseases and Treatments Ophthalmology 2 works
- 4 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 2 works
- 5 Menopause: Health Impacts and Treatments Endocrinology, Diabetes and Metabolism 2 works
- 6 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
- 7 Colorectal Cancer Treatments and Studies Oncology 2 works
- 8 Prostate Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 2 works
- 9 Hemophilia Treatment and Research Hematology 2 works
- 10 Cancer Treatment and Pharmacology Oncology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Bayer (Switzerland)'s research output changed?
Output in 2018–2022 was 118% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Basel
- University of Basel
- Novartis (Switzerland)
- University Hospital of Basel
- Roche (Switzerland)
- Swiss Tropical and Public Health Institute
- Multidisciplinary Digital Publishing Institute (Switzerland)
- University Children’s Hospital Basel
- Bank for International Settlements
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.